Back to IKT
NORTHERN TRUST CORP IKT Position History
Inhibikase Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$5K
Q3 2026
Peak value
$2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $19K |
| Q4 2025 | $642K |
| Q4 2025 | $1K |
| Q1 2026 | $25K |
| Q1 2026 | $1.2M |
| Q1 2026 | $904 |
| Q2 2026 | $39K |
| Q2 2026 | $1.7M |
| Q2 2026 | $4K |
| Q3 2026 | $43K |
| Q3 2026 | $2M |
| Q3 2026 | $5K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $5K | 2.6K | — | — |
| Q3 2026 | $2M | 979.6K | — | — |
| Q3 2026 | $43K | 20.9K | — | — |
| Q2 2026 | $4K | 1.8K | — | — |
| Q2 2026 | $1.7M | 857.7K | — | — |
| Q2 2026 | $39K | 19.1K | — | — |
| Q1 2026 | $904 | 538 | — | — |
| Q1 2026 | $1.2M | 703.4K | — | — |
| Q1 2026 | $25K | 14.9K | — | — |
| Q4 2025 | $1K | 538 | — | — |
| Q4 2025 | $642K | 313.0K | — | — |
| Q4 2025 | $19K | 9.2K | — | — |